for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Basilea Reports Activity Of Derazantinib In Preclinical Models Of Gastric Cancer

Jan 23 (Reuters) - BASILEA PHARMACEUTICA AG:

* BASILEA REPORTS ACTIVITY OF DERAZANTINIB IN PRECLINICAL MODELS OF GASTRIC CANCER AT ASCO GASTROINTESTINAL CANCERS SYMPOSIUM Source text for Eikon: Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up